Mycobacterial persistence requires the utilization of host cholesterol
about
An anaerobic-type alpha-ketoglutarate ferredoxin oxidoreductase completes the oxidative tricarboxylic acid cycle of Mycobacterium tuberculosisLipid body-phagosome interaction in macrophages during infectious diseases: host defense or pathogen survival strategy?High-resolution phenotypic profiling defines genes essential for mycobacterial growth and cholesterol catabolismStudies of a ring-cleaving dioxygenase illuminate the role of cholesterol metabolism in the pathogenesis of Mycobacterium tuberculosisCharacterization of phosphofructokinase activity in Mycobacterium tuberculosis reveals that a functional glycolytic carbon flow is necessary to limit the accumulation of toxic metabolic intermediates under hypoxiaComparative and functional genomics of Rhodococcus opacus PD630 for biofuels developmentMycobacterial outer membranes: in search of proteinsPathogen roid rage: cholesterol utilization by Mycobacterium tuberculosisMycobacterium tuberculosis utilizes a unique heterotetrameric structure for dehydrogenation of the cholesterol side chainMycobacterium tuberculosis CYP125A1, a steroid C27 monooxygenase that detoxifies intracellularly generated cholest-4-en-3-oneA flavin-dependent monooxygenase from Mycobacterium tuberculosis involved in cholesterol catabolismActivity of 3-ketosteroid 9α-hydroxylase (KshAB) indicates cholesterol side chain and ring degradation occur simultaneously in Mycobacterium tuberculosisMycobacterial cytochrome p450 125 (cyp125) catalyzes the terminal hydroxylation of c27 steroidsThe Structure of Mycobacterium tuberculosis CYP125: molecular basis for cholesterol binding in a P450 needed for host infectionCharacterization of 3-ketosteroid 9{alpha}-hydroxylase, a Rieske oxygenase in the cholesterol degradation pathway of Mycobacterium tuberculosisLiver X receptors contribute to the protective immune response against Mycobacterium tuberculosis in miceMycobacterium tuberculosis: Manipulator of Protective ImmunityUse of siRNA molecular beacons to detect and attenuate mycobacterial infection in macrophagesHeterogeneity in tuberculosis pathology, microenvironments and therapeutic responsesMycobacterium tuberculosis: success through dormancyStriking the Right Balance Determines TB or Not TBRedox homeostasis in mycobacteria: the key to tuberculosis control?Characterization of a Carbon-Carbon Hydrolase from Mycobacterium tuberculosis Involved in Cholesterol MetabolismBiochemical and structural characterization of CYP124: A methyl-branched lipid -hydroxylase from Mycobacterium tuberculosisReverse type I inhibitor of Mycobacterium tuberculosis CYP125A1Probing the architecture of the Mycobacterium marinum arylamine N-acetyltransferase active siteStructure and Catalytic Mechanism of 3-Ketosteroid- 4-(5 )-dehydrogenase from Rhodococcus jostii RHA1 GenomePiperidinols That Show Anti-Tubercular Activity as Inhibitors of Arylamine N-Acetyltransferase: An Essential Enzyme for Mycobacterial Survival Inside MacrophagesMycobacterium tuberculosis Rv3406 is a type II alkyl sulfatase capable of sulfate scavengingCrystal Structure and Site-directed Mutagenesis of 3-Ketosteroid 1-Dehydrogenase from Rhodococcus erythropolis SQ1 Explain Its Catalytic MechanismGranulomas and Inflammation: Host-Directed Therapies for Tuberculosis.TB drug development: immunology at the tableMycobacterial genes essential for the pathogen's survival in the hostHost Delivery of Favorite Meals for Intracellular PathogensFoamy macrophages and the progression of the human tuberculosis granulomaNew insights into TB physiology suggest untapped therapeutic opportunitiesMycobacteria exploit host hyaluronan for efficient extracellular replicationMetabolic regulation of mycobacterial growth and antibiotic sensitivityDifferential producibility analysis (DPA) of transcriptomic data with metabolic networks: deconstructing the metabolic response of M. tuberculosisTrehalose-recycling ABC transporter LpqY-SugA-SugB-SugC is essential for virulence of Mycobacterium tuberculosis
P2860
Q21089615-22E40113-1949-4125-BDC5-AC0F9C811DEAQ21131401-4CB7DF12-80BD-4A13-8769-84566F21E3B4Q21131409-44C67BFE-F0E3-4E90-B8D5-DA35F8A4E2F8Q21131582-D96F2D43-3202-4CA7-BA03-6313BC40954CQ21133686-EC29C3D7-9FAC-4F4C-9547-CE707ABD96FEQ21563379-80A1CC4F-5B08-471F-A22D-84ACA1A9CE8EQ22251442-BA96D50B-9524-4D3F-AA34-DCC5C42E66D6Q22305694-554F47A3-3598-41BB-97B5-82BB26DB44E5Q24594300-143C2BB4-0792-4149-9D0C-1C80AF0C31B8Q24603833-5277F004-19A5-475C-9234-13135F12C9FFQ24609899-F4272B4C-D319-4ABF-A90D-69613ED2FB0BQ24624204-65326C51-BDBB-4501-917E-C8F19C6A29BEQ24644318-3BFBD77D-BB53-4EB6-B329-A91D0B9DBEDEQ24644351-0F891913-78BB-44EA-8A56-1CD338B71F22Q24647315-2A1CCA49-AF66-45F8-BB07-562DEEC95CCEQ24652935-D846C577-6077-464C-937A-369C5481C872Q26765471-975464DD-3EC0-41FE-B44D-C546403AB9F9Q26796753-FD5F3F04-3CB0-46E1-B5B0-66AE05ABED30Q26823503-31634E27-50B6-41B4-8EFD-6A28C49AE5C3Q26852023-5E0485B4-E386-4F3C-899E-B26303F88542Q27001010-AC389EF9-92C3-41D5-A0F8-BC4325718764Q27012879-BE696506-81B1-4012-938A-D7F8178B6D3BQ27658021-8E759A80-12B2-41AE-8379-A6998CB77B4DQ27658311-279B593B-4F86-42CF-A3DD-E3C4BE5029F1Q27666066-E6E0E151-8D6A-42B6-A1F0-3B7DC9B1A600Q27666450-12A21258-D1C3-49D0-8D03-C34FA96765DCQ27670912-7D6C3FB1-40FA-48D1-8A4F-F9DE25C7C51FQ27675714-F4DBF2DD-D632-4269-B9AE-680000044F9DQ27678602-11D0B1C0-5AE2-4825-80AA-730760594089Q27680470-985304D0-6D40-41D5-A404-11D047E5D9E1Q28076037-1B314D1C-0E85-4366-BB5C-3E436C629F36Q28083600-1D78ECD6-F677-4391-A04E-AD36F00ABB1CQ28083739-48E397DC-AEBB-4D3E-9153-04C9456B905BQ28087165-26155655-7047-4C99-A494-332D2842EBC5Q28255669-BD65DF02-6623-472A-A01B-09165306FA39Q28388477-F2AE8147-CBBA-476B-AC89-8DC312355576Q28471614-B54841CC-4334-4240-A3FE-9F2D746ABD0AQ28478251-081DF4BC-0D63-41A6-AA30-31FA3E0A37D3Q28478889-CC9C6734-3708-444D-9C12-2BB020A5F65DQ28486356-BC5EC2D9-2F53-471F-947F-B3D8416AECB3
P2860
Mycobacterial persistence requires the utilization of host cholesterol
description
2008 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի մարտին հրատարակված գիտական հոդված
@hy
article publié dans les Procee ...... f the United States of America
@fr
artículu científicu espublizáu en 2008
@ast
im März 2008 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2008/03/18)
@sk
vědecký článek publikovaný v roce 2008
@cs
wetenschappelijk artikel (gepubliceerd op 2008/03/18)
@nl
наукова стаття, опублікована в березні 2008
@uk
name
Mycobacterial persistence requires the utilization of host cholesterol
@ast
Mycobacterial persistence requires the utilization of host cholesterol
@en
Mycobacterial persistence requires the utilization of host cholesterol
@nl
type
label
Mycobacterial persistence requires the utilization of host cholesterol
@ast
Mycobacterial persistence requires the utilization of host cholesterol
@en
Mycobacterial persistence requires the utilization of host cholesterol
@nl
prefLabel
Mycobacterial persistence requires the utilization of host cholesterol
@ast
Mycobacterial persistence requires the utilization of host cholesterol
@en
Mycobacterial persistence requires the utilization of host cholesterol
@nl
P2860
P3181
P356
P1476
Mycobacterial persistence requires the utilization of host cholesterol
@en
P2093
Amit K. Pandey
Christopher M. Sassetti
P2860
P304
P3181
P356
10.1073/PNAS.0711159105
P407
P577
2008-03-18T00:00:00Z